Loading...
Loading...
Application UK00901874064 · DO-NOT-DISPLAY

| Application Number | UK00901874064 |
| Status | DO-NOT-DISPLAY |
| Owner | Astellas Pharma Inc. |
| Filed | 2000-09-26 |
| Registered | 2002-01-16 |
| Renewal Due | 2020-09-26 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
UK00901874064 has a current status of DO-NOT-DISPLAY.
WOWTAB DESIGN
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Swallow-facilitating component of pharmaceutical preparations for the treatment of disease of health-related conditions involving blood and blood-forming organs, the cardiac circulatory systems, the peripheral vascular circulatory system, the endocrine system, the genitourinary system, the immune system, infectious and parasitic conditions, the upper and lower digestive system, mental disorders, metabolic disorders, multi-system and ill-defined conditions, musculoskeletal systems and connective tissue, neoplasms, the nervous system, nutritional disorders, pregnancy, the respiratory system, sensory organ conditions, skin and subcutaneous conditions; pharmaceutical, veterinary and sanitary preparations and substances; medical tablets.
This figurative mark is indexed under the following Vienna categories by the UK IPO:
This device mark (application number UK00901874064) is a do-not-display trademark on the UK IPO register, filed by Astellas Pharma Inc. on 26 September 2000, with registration granted on 16 January 2002. It is due to expire on 26 September 2020.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations), specifically covering: WOWTAB DESIGN
The trademark is represented by Inge Visscher Astellas Pharma Europe B.V..
No — the UK IPO records the status of UK trademark UK00901874064 as do-not-display.
UK trademark UK00901874064 is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Swallow-facilitating component of pharmaceutical preparations for the treatment of disease of health-related conditions involving blood and blood-forming organs, the cardiac circulatory systems, the peripheral vascular circulatory system, the endocrine system, the genitourinary system, the immune system, in…
UK trademark UK00901874064 was filed at the UK IPO on 26 September 2000 and registered on 16 January 2002.
UK trademark UK00901874064 is currently recorded as valid until 26 September 2020, at which point it will need to be renewed with the UK IPO to remain in force.
Inge Visscher Astellas Pharma Europe B.V. is listed as the attorney / representative of record for UK trademark UK00901874064 on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.